Nakamura T, Yoneda M, Irie T, Kumasaka Y, Yoshida S, Ohmi T, Okamoto K, Takebe K
Jpn J Antibiot. 1985 Sep;38(9):2489-95.
A newly developed human immunoglobulin preparation for intravenous administration (SM-4300) was applied to the severe bacterial infections in the field of internal medicine. Nine cases of severe infections were treated with SM-4300 and antibiotics combination. Clinical effects of SM-4300 were excellent in 1 case, good in 5, poor in 1 and unknown in 2. The efficacy rate was summarized as 86%, and no side effects were observed.
一种新研发的静脉注射用人免疫球蛋白制剂(SM - 4300)被应用于内科领域的严重细菌感染。9例严重感染患者接受了SM - 4300与抗生素联合治疗。SM - 4300的临床效果为1例优,5例良,1例差,2例未知。总有效率为86%,未观察到副作用。